Stephen Williamson - Nov 2, 2021 Form 4 Insider Report for THERMO FISHER SCIENTIFIC INC. (TMO)

Role
Sr. VP and CFO
Signature
/s/ Melodie T. Morin, Attorney-in-Fact for Stephen Williamson
Stock symbol
TMO
Transactions as of
Nov 2, 2021
Transactions value $
-$11,462,731
Form type
4
Date filed
11/3/2021, 04:34 PM
Previous filing
Nov 3, 2021
Next filing
Feb 25, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Ownership Footnotes
transaction TMO Common Stock +Options Exercise $2,926,314 +22,550 +56.07% $129.77 62,771 Nov 2, 2021 Direct
transaction TMO Common Stock -Sell -$189,978 -300 -0.48% $633.26 62,471 Nov 2, 2021 Direct F1, F2
transaction TMO Common Stock -Sell -$253,768 -400 -0.64% $634.42 62,071 Nov 2, 2021 Direct F1, F3
transaction TMO Common Stock -Sell -$2,363,008 -3,717 -5.99% $635.73 58,354 Nov 2, 2021 Direct F1, F4
transaction TMO Common Stock -Sell -$2,601,042 -4,085 -7% $636.73 54,269 Nov 2, 2021 Direct F1, F5
transaction TMO Common Stock -Sell -$2,325,036 -3,645 -6.72% $637.87 50,624 Nov 2, 2021 Direct F1, F6
transaction TMO Common Stock -Sell -$3,041,497 -4,760 -9.4% $638.97 45,864 Nov 2, 2021 Direct F1, F7
transaction TMO Common Stock -Sell -$2,021,697 -3,159 -6.89% $639.98 42,705 Nov 2, 2021 Direct F1, F8
transaction TMO Common Stock -Sell -$1,079,309 -1,684 -3.94% $640.92 41,021 Nov 2, 2021 Direct F1, F9
transaction TMO Common Stock -Sell -$449,421 -700 -1.71% $642.03 40,321 Nov 2, 2021 Direct F1, F10
transaction TMO Common Stock -Sell -$64,288 -100 -0.25% $642.88 40,221 Nov 2, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TMO Stock Option (Right to Buy) -Options Exercise $0 -22,550 -100% $0.00 0 Nov 2, 2021 Common Stock 22,550 $129.77 Direct F11

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2021.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $632.96 to $633.41, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4), (5), (6), (7), (8), (9) and (10) to this Form 4.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $634.05 to $634.86, inclusive.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $635.315 to $636.11, inclusive.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $636.33 to $637.32, inclusive.
F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $637.41 to $638.39, inclusive.
F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $638.45 to $639.435, inclusive.
F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $639.46 to $640.44, inclusive.
F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $640.595 to $641.59, inclusive.
F10 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $641.60 to $642.33, inclusive.
F11 The option vested in four equal installments on February 24, 2017, 2018, 2019, and 2020.